J7316
HCPCSInj, ocriplasmin, 0.125 mg
Official HCPCS Level II long descriptor
Injection, ocriplasmin, 0.125 mg
HCPCS Level II code J7316 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, ocriplasmin, 0.125 mg
Added to HCPCS: 2014-01-01
Nearby codes in J7
- J7306Levonorgestrel implant sys
- J7307Etonogestrel implant system
- J7308Aminolevulinic acid hcl top
- J7311Inj., retisert, 0.01 mg
- J7312Dexamethasone intra implant
- J7313Inj., iluvien, 0.01 mg
- J7314Inj., yutiq, 0.01 mg
- J7315Ophthalmic mitomycin
- J7318Inj, durolane 1 mg
- J7320Genvisc 850, inj, 1mg
- J7321Hyalgan supartz visco-3 dose
- J7322Hyaluronan, hymo or hymo one
- J7323Euflexxa inj per dose
- J7324Orthovisc inj per dose
- J7325Synvisc or synvisc-one
- J7326Gel-one
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.